Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies
- PMID: 11552003
- DOI: 10.1212/wnl.57.5.780
Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies
Abstract
Objective: To characterize the specificity of anti-GAD(65) antibodies in patients with stiff person syndrome (SPS), quantify antibody titers, and examine antibody production within the CNS.
Methods: The authors studied 18 patients with SPS and positive serum immunoreactivity to gamma-aminobutyric acid (GABA)-ergic neurons. The reactivity of serum and CSF to purified GAD antigen was examined by Western blots, and the anti-GAD(65) antibody titers in serum and CSF were quantified by ELISA and compared with 70 disease controls (49 with other autoimmune disorders and 11 with insulin-dependent diabetes mellitus). The intrathecal synthesis of anti-GAD(65) IgG was calculated, and the functional significance of the antibodies was examined by measuring the GABA levels in the CSF.
Results: The serum and CSF of all selected patients with SPS had high anti-GAD(65) titers (from 7.0 to 215 microg/mL in serum and from 92 to 2500 ng/mL in CSF) and immunoreacted strongly with recombinant GAD(65) on Western blots and with GABA-ergic neurons on rat cerebellum. Among controls, only the serum of eight patients with insulin-dependent diabetes mellitus had low anti-GAD(65) antibody titers (from 200 to 1760 ng/mL) but no reactivity to recombinant GAD(65). The CSF showed oligoclonal IgG bands in 10 (67%) of 15 patients and an increased anti-GAD(65)-specific IgG index in 11 (85%) of 13. The mean level of GABA in the CSF was lower in patients with SPS than in controls.
Conclusions: In patients with SPS, there is marked intrathecal antibody response against neuronal GAD(65) epitopes, indicating a clonal B cell activation in the CNS. Anti-GAD(65) antibodies at high titers, when confirmed with immunoblots, are highly specific for SPS and appear to impair GABA synthesis.
Similar articles
-
Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.Arch Neurol. 2004 Jun;61(6):902-4. doi: 10.1001/archneur.61.6.902. Arch Neurol. 2004. PMID: 15210528
-
GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.Eur J Neurol. 2008 Sep;15(9):973-80. doi: 10.1111/j.1468-1331.2008.02221.x. Epub 2008 Jul 10. Eur J Neurol. 2008. PMID: 18637036
-
Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.Ann Neurol. 1998 Aug;44(2):194-201. doi: 10.1002/ana.410440209. Ann Neurol. 1998. PMID: 9708541
-
Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.J Autoimmun. 2011 Sep;37(2):79-87. doi: 10.1016/j.jaut.2011.05.005. Epub 2011 Jun 16. J Autoimmun. 2011. PMID: 21680149 Review.
-
Stiff Person Syndrome and GAD Antibody-Spectrum Disorders.Continuum (Minneap Minn). 2024 Aug 1;30(4):1110-1135. doi: 10.1212/CON.0000000000001457. Continuum (Minneap Minn). 2024. PMID: 39088290 Review.
Cited by
-
Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome.Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e281. doi: 10.1212/NXI.0000000000000281. eCollection 2016 Oct. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27606356 Free PMC article. No abstract available.
-
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.Neurol Neuroimmunol Neuroinflamm. 2021 Oct 1;8(6):e1088. doi: 10.1212/NXI.0000000000001088. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34599001 Free PMC article.
-
Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.Front Immunol. 2017 Apr 25;8:395. doi: 10.3389/fimmu.2017.00395. eCollection 2017. Front Immunol. 2017. PMID: 28487693 Free PMC article. Review.
-
Ten Years of Neurology® Neuroimmunology & Neuroinflammation: Decade in Review.Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200363. doi: 10.1212/NXI.0000000000200363. Epub 2024 Dec 26. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39724529 Free PMC article. No abstract available.
-
Low-titer anti-GAD-antibody-positive cerebellar ataxia.Cerebellum. 2013 Apr;12(2):171-5. doi: 10.1007/s12311-012-0411-5. Cerebellum. 2013. PMID: 22923147
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical